Welcome!

News Feed Item

CannaVest Corp. Announces Filing of Restated Financial Statements

LAS VEGAS, April 25, 2014 /PRNewswire/ -- CannaVest Corp. - ("CannaVest" or "the Company") (OTC BB: CANV) today announced that it has filed restated financial statements and accompanying management's discussion and analysis for the quarters ended March 31, June 30, and September 30, 2013. 

CannaVest Corp - The World's Leading Industrial Hemp Supplier.

As indicated in the Company's Form 10-K filed on March 28, 2014, the restatements were determined to be necessary as a result of the audit of the December 31, 2013 financial statements and following consultation with the Company's external auditors.  The purpose of the restatement is to address the following items, which the Company has identified as requiring correction:

Recognition of revenue
The financial statements for the quarter ended March 31, 2013 reflected revenue and accounts receivable of $192,625 and cost of goods sold of $296,050 that should not have been recognized.  Revenues and accounts receivable in the amount of $192,625 related to the sales value of inventory that was transferred to a manufacturer for inclusion in finished goods and an error in calculating the price of the ending inventory as of the end of the period. The amount of $39,865 was related to the cost of inventory sent for manufacturing being included in cost of goods sold and $256,185 related to errors related to calculating ending inventory.

Prepaid inventory
A portion of the prepaid inventory purchased as part of the Company's acquisition of assets from PhytoSPHERE Systems, LLC ("PhytoSPHERE") was not included in the financial statements as of March 31, 2013.  The resulting understatement of prepaid inventory was $1,260,510.

Inventory
Inventory as originally reported in the financial statements ended March 31, 2013, was understated by $125,027.  This was a result of an overstatement of cost of goods sold in the amount of $296,050, offset by an adjustment for the value of inventory acquired from PhytoSPHERE in the amount of $171,023

Value of intangible assets
Intangible assets as presented in the financial statements as of March 31, June 30 and September 30, 2013 were in error.  As determined by the valuation of the assets purchased from PhytoSPHERE, intangible assets totaled $4,110,000. Net intangible assets previously reported at March 31, 2013 were $33,656,833, which represents an overstatement of $29,683,833.  Net intangible assets previously reported at June 30, 2013 were $4,995,895, which represents an overstatement of $1,228,395 and net intangible assets previously reported at September 30, 2013 were $4,466,666, resulting in an overstatement of $904,666.

Goodwill
As determined by the valuation of assets purchased from PhytoSPHERE, the value of goodwill was $1,855,512.  The Company did not report any goodwill as of March 31, 2013, which resulted in an understatement of $1,855,512.  At June 30, 2013, the Company reported goodwill in the amount of $26,998,125, resulting in an overstatement of goodwill of $25,142,613.  At September 30, 2013, the Company recorded impairment of goodwill in the amount of $26,998,125, resulting in a carrying value of $0.  This resulted in an understatement of goodwill in the amount of $1,855,512.

Amount due to PhytoSPHERE Systems; Additional paid in capital
The amount due to PhytoSPHERE was originally reported as $35 million, pursuant to the terms of the agreement.  Shares to be issued as payment under the transaction were at a set per share price between $4.50 and $6.00.  Subsequently, a valuation determined the price of the transaction to be $8,020,000, which resulted in a per share price of $1.21 per sharebased on the valuation obtained.  Therefore, for the Company's financial reports, the amount due to PhytoSPHERE was adjusted to $8,020,000 and the shares issued as payment pursuant to the transaction were adjusted to $1.21 per share.  This resulted in an overstatement of the amount due PhytoSPHERE and paid-in capital of $23,572,360 and $3,407,640, respectively at March 31, 2013; $18,786,094 and $8,193,906, respectively at June 30, 2013; and $5,185,120 and $21,794,880, respectively at September 30, 2013.

Amortization expense
The restatement of the value of intangible assets has resulted in the overstatement of amortization expense for the quarters ended March 31, June 30 and September 30, 2013 in the amount of $241,167, $367,825 and $323,730, respectively.  The overstatement of amortization expense was $608,992 for the six months ended June 30, 2013 and $932,722 for the nine months ended September 30, 2013.

Impairment of goodwill
The Company originally reported $26,998,125 as an impairment to goodwill for the quarter ended September 30, 2013.  The Company did not record an impairment to goodwill in its restated financial statements.  This resulted in an overstatement of operating expenses of $26,998,125 for the three and nine months ended September 30, 2013.

Research & development expenses
For the quarter ended September 30, 2013, the Company included $137,496 in research and development expenses as a part of general and administrative expenses.  This amount has been reported as research and development expenses in the restated financial statements.

The cumulative impact on the Company's financial statements are described in more detail below.

For the three months ended March 31, 2013

The effect of these adjustments on the condensed balance sheet as of March 31, 2013 is summarized below:


As previously reported



Adjustment



As restated


Accounts receivable

$

1,671,438



$

(192,625)



$

1,478,813


Prepaid inventory


194,206




1,260,510




1,454,716


Inventory


725,000




125,027




850,027


Intangible assets (net)


33,656,833




(29,683,833)




3,973,000


Goodwill





1,855,512




1,855,512


Amount due under the PhytoSPHERE Agreement


30,500,000




(23,572,360)




6,927,640


Additional paid in capital


4,643,357




(3,407,640)




1,235,717


Retained earnings


193,725




344,592




538,317


The effect of these adjustments on the condensed statement of operations for the three months ended March 31, 2013 is as follows:


As previously reported



Adjustment



As restated


Revenue

$

1,275,000



$

(192,625)



$

1,082,375


Cost of goods sold


501,500




(296,050)




205,450


General and administrative expenses


435,559




(241,167)




194,392


Net income


337,941




344,592




682,533


Earnings per share


0.04




0.05




0.09


The effect of these adjustments on the condensed statement of cash flows for the three months ended March 31, 2013 is as follows:


As previously reported



Adjustment



As restated


Net income

$

337,941



$

344,592



$

682,533


Amortization expense


378,167




(241,167)




137,000


Prepaid inventory





(194,206)




(194,206)


Inventory


(402,707)




(101,843)




(504,550)


Accounts receivable


(1,275,000)




192,625




(1,082,375)


For the three and six months ended June 30, 2013

The effect of these adjustments on the condensed consolidated balance sheet as of June 30, 2013 is summarized below:


As previously reported



Adjustment



As restated



Intangible assets (net)

$

4,995,895



$

(1,228,395)



$

3,767,500



Goodwill


26,998,125




(25,142,613)




1,855,512


Amount due under the PhytoSPHERE Agreement


23,750,000




(18,786,094)




4,963,906


Additional paid in capital


10,643,257




(8,193,906)




2,449,351


Retained earnings  (accumulated deficit)


(418,809)




608,992




190,183
















The effect of these adjustments on the condensed consolidated statement of operations for the three months ended June 30, 2013 is as follows:


As previously reported



Adjustment



As restated


General and administrative expenses

$

1,131,660



$

(712,658)



$

419,002


Net income (loss)


(1,060,792)




712,658




(348,134)


Earnings (loss) per share


(0.12)




0.08




(0.04)


The effect of these adjustments on the condensed consolidated statement of operations for the six months ended June 30, 2013 is as follows:


As previously reported



Adjustment



As restated


General and administrative expenses

$

1,222,386



$

(608,992)



$

613,394


Net income (loss)


(274,593)




608,992




334,399


Earnings (loss) per share


(0.03)




0.07




0.04


The effect of these adjustments on the condensed consolidated statement of cash flows for the six months ended June 30, 2013 is as follows:


As previously reported



Adjustment



As restated


Net income (loss)

$

(274,593)



$

608,992



$

334,399


Amortization expense


951,492




(608,992)




342,500


Inventory


(1,832,345)




(1)




(1,832,346)


Accounts receivable


(1,165,059)




1




(1,165,058)


For the three and nine months ended September 30, 2013

The effect of these adjustments on the condensed consolidated balance sheet as of September 30, 2013 is summarized below:


As previously reported



Adjustment



As restated



Intangible assets (net)

$

4,466,666



$

(904,666)



$

3,562,000



Goodwill





1,855,512




1,855,512


Amount due under the PhytoSPHERE Agreement


6,499,998




(5,185,120)




1,314,878


Additional paid in capital


28,330,375




(21,794,880)




6,535,495


Accumulated deficit


(28,551,425)




27,930,847




(620,578)
















The effect of these adjustments on the condensed consolidated statement of operations for the three months ended September 30, 2013 is as follows:


As previously reported



Adjustment



As restated


General and administrative expenses

$

1,115,098



$

(461,226)



$

653,872



Impairment of goodwill


26,998,125




(26,998,125)






Research and development expenses





137,496




137,496



Net income (loss)


(28,132,616)




27,321,855




(810,761)



Earnings per share


(2.81)




2.73




(0.08)

















The effect of these adjustments on the condensed consolidated statement of operations for the nine months ended September 30, 2013 is as follows:


As previously reported



Adjustment



As restated


General and administrative expenses

$

2,337,484



$

(1,070,218)



$

1,267,266


Impairment of goodwill


26,998,125




(26,998,125)





Research and development expenses





137,496




137,496


Net income (loss)


(28,407,209)




27,930,847




(476,362)


Earnings per share


(3.21)




3.26




(0.05)

















The effect of these adjustments on the condensed consolidated statement of cash flows for the nine months ended September 30, 2013 is as follows:


As previously reported



Adjustment



As restated


Net income (loss)

$

(28,407,209)



$

27,930,847



$

(476,362)


Amortization expense


1,480,722




(932,722)




548,000


Impairment of goodwill


26,998,125




(26,998,125)





The restated financial statements and accompanying management discussion and analysis have been filed with the United States Securities and Exchange Commission ("SEC") through the EDGAR system.

"In the process of going through our year end audit, we discussed the issues that had come to light with our external auditors which were primarily attributable to the accounting of the PhytoSPHERE transaction," said Michael J. Mona, Jr., President and Chief Executive Officer of CannaVest.  "While this has been a tough process that we would have preferred not to endure, our goal is and has been that our filings are accurate and that the public can rely on them going forward."  Mona added, "We have a lot of exciting developments in the coming months.  The sooner we can move past this restatement, the better. Once we decided to pursue restating the financial statements, we wanted to move as quickly as possible to insure that the most accurate information is publicly available."

For a further discussion of the Company's financial results for the year ended December 31, 2013, please refer to the Company's consolidated financial statements and related Management Discussion and Analysis, which can be found at www.cannavest.com or EDGAR at www.sec.gov/edgar/searchedgar/webusers.htm

About CannaVest Corp.
CannaVest Corp. is in the business of investing and developing hemp-based cannabinoid companies. CannaVest Corp. develops, produces, markets and sells end-consumer products to the nutraceutical industry containing the hemp plant extract, cannabidiol (CBD). Additionally, the company resells raw product acquired by CannaVest Corp. Pursuant to the company's supply relationships in Europe, CannaVest Corp. seeks to take advantage of an emerging worldwide trend to re-energize the production of industrial hemp and to foster its many uses for consumers. Cannabinoids (cannabidiol/CBD) are natural constituents of the hemp plant, and CBD is derived from hemp stalk and seed. Additional information is available from OTCMarkets.com or by visiting CannaVest.com.

About PhytoSPHERE Systems
Phytosphere Systems is a global phytocannabinoid biotechnology company and a wholly-owned subsidiary of CannaVest Corp. (OTCBB:CANV). The company utilizes advanced cultivation methods and state-of-the-art processing technology leading to development of pharmaceutical, nutraceutical and food products.

Phytosphere Systems, the manufacturer of the CBD-rich hemp oil used in Real Scientific Hemp Oil (RSHO), has developed special cultivars (similar to "strains") that produce hemp that is especially rich in CBD, making it possible for Phytosphere to offer all-natural products with high concentrations of hemp-based CBD. For more information, please visit: Phytospheresystems.com.

About US Hemp Oil
US Hemp Oil seeks to develop the United States industrial hemp industry. The company is dedicated to the procurement, processing, marketing and distribution of bulk wholesale hemp seed, hemp oil, protein, food and hemp body care products. US Hemp Oil currently has three brands: RSHO™, Cibaderm™, and Cibdex™. US Hemp Oil is determined to bring hemp products into the mainstream by creating greater public awareness of and media exposure for the exceptional nutritional profile of hemp and the environmental benefits of growing industrial hemp. For more information, please visit: USHempOil.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaVest Corp. to be materially different from the statements made herein.

LEGAL DISCLOSURE

CannaVest Corp. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets.

Corporate Contact:
CannaVest Corp.
2688 S. Rainbow Blvd., Ste. B
Las Vegas, NV 89146
Office: 866-290-2157

Photo - http://photos.prnewswire.com/prnh/20140403/LA98016LOGO

SOURCE CannaVest Corp.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
If there is anything we have learned by now, is that every business paves their own unique path for releasing software- every pipeline, implementation and practices are a bit different, and DevOps comes in all shapes and sizes. Software delivery practices are often comprised of set of several complementing (or even competing) methodologies – such as leveraging Agile, DevOps and even a mix of ITIL, to create the combination that’s most suitable for your organization and that maximize your busines...
Struggling to keep up with increasing application demand? Learn how Platform as a Service (PaaS) can streamline application development processes and make resource management easy.
In his session at @ThingsExpo, Chris Klein, CEO and Co-founder of Rachio, will discuss next generation communities that are using IoT to create more sustainable, intelligent communities. One example is Sterling Ranch, a 10,000 home development that – with the help of Siemens – will integrate IoT technology into the community to provide residents with energy and water savings as well as intelligent security. Everything from stop lights to sprinkler systems to building infrastructures will run ef...
SYS-CON Events announced today that Peak 10, Inc., a national IT infrastructure and cloud services provider, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Peak 10 provides reliable, tailored data center and network services, cloud and managed services. Its solutions are designed to scale and adapt to customers’ changing business needs, enabling them to lower costs, improve performance and focus inter...
You think you know what’s in your data. But do you? Most organizations are now aware of the business intelligence represented by their data. Data science stands to take this to a level you never thought of – literally. The techniques of data science, when used with the capabilities of Big Data technologies, can make connections you had not yet imagined, helping you discover new insights and ask new questions of your data. In his session at @ThingsExpo, Sarbjit Sarkaria, data science team lead ...
Whether your IoT service is connecting cars, homes, appliances, wearable, cameras or other devices, one question hangs in the balance – how do you actually make money from this service? The ability to turn your IoT service into profit requires the ability to create a monetization strategy that is flexible, scalable and working for you in real-time. It must be a transparent, smoothly implemented strategy that all stakeholders – from customers to the board – will be able to understand and comprehe...
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, will provide tips on how to be successful in large scale machine lear...
Machine Learning helps make complex systems more efficient. By applying advanced Machine Learning techniques such as Cognitive Fingerprinting, wind project operators can utilize these tools to learn from collected data, detect regular patterns, and optimize their own operations. In his session at 18th Cloud Expo, Stuart Gillen, Director of Business Development at SparkCognition, will discuss how research has demonstrated the value of Machine Learning in delivering next generation analytics to im...
In the world of DevOps there are ‘known good practices’ – aka ‘patterns’ – and ‘known bad practices’ – aka ‘anti-patterns.' Many of these patterns and anti-patterns have been developed from real world experience, especially by the early adopters of DevOps theory; but many are more feasible in theory than in practice, especially for more recent entrants to the DevOps scene. In this power panel at @DevOpsSummit at 18th Cloud Expo, moderated by DevOps Conference Chair Andi Mann, panelists will dis...
See storage differently! Storage performance problems have only gotten worse and harder to solve as applications have become largely virtualized and moved to a cloud-based infrastructure. Storage performance in a virtualized environment is not just about IOPS, it is about how well that potential performance is guaranteed to individual VMs for these apps as the number of VMs keep going up real time. In his session at 18th Cloud Expo, Dhiraj Sehgal, in product and marketing at Tintri, will discu...
Unless you don’t use the internet, don’t live in California, or haven’t been paying attention to the recent news… you should be aware that self-driving cars are on their way to becoming a reality. I have seen them – they are real. If you believe in the future reality of self-driving cars, then continue reading on. If you don’t believe in the future possibilities, then I am not sure what to do to convince you other than discuss the very real changes that will roll out with the consumer producti...
Up until last year, enterprises that were looking into cloud services usually undertook a long-term pilot with one of the large cloud providers, running test and dev workloads in the cloud. With cloud’s transition to mainstream adoption in 2015, and with enterprises migrating more and more workloads into the cloud and in between public and private environments, the single-provider approach must be revisited. In his session at 18th Cloud Expo, Yoav Mor, multi-cloud solution evangelist at Cloudy...
There is an ever-growing explosion of new devices that are connected to the Internet using “cloud” solutions. This rapid growth is creating a massive new demand for efficient access to data. And it’s not just about connecting to that data anymore. This new demand is bringing new issues and challenges and it is important for companies to scale for the coming growth. And with that scaling comes the need for greater security, gathering and data analysis, storage, connectivity and, of course, the...
This is not a small hotel event. It is also not a big vendor party where politicians and entertainers are more important than real content. This is Cloud Expo, the world's longest-running conference and exhibition focused on Cloud Computing and all that it entails. If you want serious presentations and valuable insight about Cloud Computing for three straight days, then register now for Cloud Expo.
IoT device adoption is growing at staggering rates, and with it comes opportunity for developers to meet consumer demand for an ever more connected world. Wireless communication is the key part of the encompassing components of any IoT device. Wireless connectivity enhances the device utility at the expense of ease of use and deployment challenges. Since connectivity is fundamental for IoT device development, engineers must understand how to overcome the hurdles inherent in incorporating multipl...